Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.550 | 0.550 | 0.000 |
Shares | 58.980 | 58.980 | 0.000 |
Bonds | 38.970 | 38.970 | 0.000 |
Convertible | 0.600 | 0.600 | 0.000 |
Preferred | 0.520 | 0.520 | 0.000 |
Other | 0.370 | 0.370 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.822 | 15.085 |
Price to Book | 2.072 | 2.092 |
Price to Sales | 1.167 | 1.551 |
Price to Cash Flow | 8.069 | 8.712 |
Dividend Yield | 2.003 | 2.599 |
5 Years Earnings Growth | 12.468 | 12.434 |
Name | Net % | Category Average |
---|---|---|
Technology | 26.450 | 17.337 |
Healthcare | 19.660 | 12.301 |
Industrials | 11.810 | 12.014 |
Basic Materials | 11.380 | 5.749 |
Consumer Defensive | 10.630 | 6.823 |
Financial Services | 7.280 | 16.672 |
Energy | 6.540 | 5.544 |
Consumer Cyclical | 6.250 | 12.770 |
Number of long holdings: 153
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CVS Health Corp | US1266501006 | 3.00 | 55.81 | -1.15% | |
PepsiCo | US7134481081 | 2.80 | 165.59 | -0.30% | |
Arab Rep Egypt | - | 2.76 | - | - | |
Linde PLC | IE000S9YS762 | 2.64 | 421.400 | -0.33% | |
Cisco | US17275R1023 | 2.46 | 55.50 | +1.33% | |
Exxon Mobil | US30231G1022 | 2.44 | 114.95 | -1.57% | |
Microsoft | US5949181045 | 2.41 | 410.37 | +0.99% | |
Thermo Fisher Scientific | US8835561023 | 2.33 | 557.92 | +2.12% | |
Newmont Goldcorp | US6516391066 | 2.24 | 45.26 | -0.40% | |
Bristol-Myers Squibb | US1101221083 | 2.05 | 54.32 | -2.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pioneer Zrownowazony | 644.1M | 18.66 | 7.63 | 1.12 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review